CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 6,000 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04610515
NCT04610515N/ACompleted
CompareCT.gov

Innovative Support for Patients With SARS-COV2 Infections (COVID-19) Registry (INSPIRE)

Rush University Medical Center·observational·Posted Oct 30, 2020·Updated Nov 14, 2025

In Brief

An observational study for Covid19 and 5 related conditions. Completed, enrolled 6,000 participants across 8 sites.

Detailed Summary

The Innovative Support for Patients with SARS COV-2 Infections Registry (INSPIRE) study is a CDC-funded COVID-19 project to understand the long-term health outcomes in recently tested adults, both negative and positive, who have suspected COVID symptoms at the time of their test. Participants will complete short online surveys every 3 months for 18 months, share information about their health using a secure web-based platform, and are compensated for their time.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCovid19, ME/CFS, SARS COV2, Novel Coronavirus Infection, Neurocognitive Disorders, Cardiovascular Diseases
CountriesUnited States
CollaboratorsYale University, University of Washington, Thomas Jefferson University, University of California, Los Angeles, University of California, San Francisco, University of Texas Southwestern Medical Center, The University of Texas Health Science Center, Houston

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedOct 30, 2020
Enrollment StartDec 15, 2020
Primary CompletionAug 31, 2024
Study CompletionOct 31, 2025
TodayJul 2, 2026
Enrollment to primary: 3.7 yearsPosted 5.7 years ago